Up 44% this year: 2 ASX 200 'recovery' shares starting to rocket

Momentum is more important than you think when buying stocks. Here's a rising pair that one expert is bullish on.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While business fundamentals are important, momentum also has a role when investing in ASX shares.

Yes, the share price theoretically should reflect how well the company is going. But it's also a reflection of how popular the stock is.

The underlying business could be super profitable with customers lining up, but if investors flee then the stock price will head down.

So let's take a look at two S&P/ASX 200 Index (ASX: XJO) shares that have gone gangbusters so far this year, which one expert reckons has more to come:

A man in business suit wearing old fashioned pilot's leather headgear, goggles and scarf bounces on a pogo stick in a dry, arid environment with nothing else around except distant hills in the background.

Image source: Getty Images

'Long and bullish'

Despite rising interest rates dampening the housing market, construction materials provider James Hardie Industries plc (ASX: JHX) has seen its shares rocket 44% year to date.

Shaw and Partners portfolio manager James Gerrish attributed this rise to "a positive interpretation of its results".

"James Hardie is a manufacturer of fibre cement building products, with operations across North America, Europe and Asia-Pacific," he said in Market Matters.

"We still see greater than 25% North America EBIT margin as the key upside from the FY23 result."

Despite the steep run up in its valuation, his team continues to be "long and bullish" for James Hardie shares.

"We note the… chart pattern of a 'recovery stock'. i.e. As we often say, the markets are like a jigsaw where you need to predict the final picture without all of the pieces," Gerrish said.

"We are initially targeting ~$40 for JHX but believe surprises are likely to be on the upside."

James Hardie shares closed Monday at $37.78.

Kicking goals on the other side of the world

Coincidentally, shares for travel agent Corporate Travel Management Ltd (ASX: CTD) are also 44% higher than where they started 2023.

According to Gerrish, the main driver of this was a massive contract win in the United Kingdom.

"[The deal] highlighted the strength of the UK business plus the way Corporate Travel is regarded by the UK government," he said.

"We estimate a potential upside of 10% to 13% from the contract which has been reflected by the share price."

Perhaps this one is a bit closer to its peak than James Hardie, which makes Gerrish's team wait for $2 to $3 pullbacks before buying.

Regardless, he said the stock is "looking well positioned through 2023".

"The company differentiates itself from competitors through its superior technology offering and its return on investment focus, which aims to reduce clients' overall travel spend."

Motley Fool contributor Tony Yoo has positions in Corporate Travel Management. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

An oil refinery worker checks her laptop computer in front of a backdrop of oil refinery infrastructure.
Broker Notes

With oil prices falling, should I still buy Santos shares now?

A leading analyst provides his forecast for Santos' outperforming share price.

Read more »

Two ASX share investors sharing a secret.
Broker Notes

Buy, hold, sell: Flight Centre, Supply Network, Lottery Corporation shares

Experts reveal their ratings on three ASX shares in the consumer discretionary sector.

Read more »

Six smiling health workers pose for a selfie.
Broker Notes

Buy, hold, sell: Charter Hall, Northern Star, Cochlear shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Down 53%, is it time to throw in the towel on CSL shares?

A leading analyst delivers his verdict on CSL’s plunging share price.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Up 293%! Can Electro Optic Systems (EOS) shares keep rising?

Bell Potter believes this high-flying stock hasn't peaked yet.

Read more »

Five healthcare workers standing together and smiling.
Broker Notes

Up 21% since November, should I buy this dividend paying ASX All Ords healthcare share today?

A leading expert tips one ASX All Ords share to buy and one to sell today.

Read more »

Time to sell written on a clock.
Broker Notes

3 reasons why experts think CSL shares are a sell

Earnings pressure and downgrades weigh heavily on the biotech stock.

Read more »

gold, gold miner, gold discovery, gold nugget, gold price,
Broker Notes

With the gold price up on Monday, are Northern Star shares a good buy now?

A leading analyst provides his outlook for Northern Star’s shares.

Read more »